XML 115 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment and Geographic Data
 12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Segment and Geographic Data SEGMENT AND GEOGRAPHIC DATA
We segregate our operations into three reportable business segments: Orthopaedics, MedSurg, and Neurotechnology and Spine.
The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.
Segment Results
 
 
 
 
2019
2018
2017
Orthopaedics
$
5,252

$
4,991

$
4,713

MedSurg
$
6,574

6,045

5,557

Neurotechnology & Spine
3,058

2,565

2,174

Net sales
$
14,884

$
13,601

$
12,444

Orthopaedics
$
348

$
350

$
337

MedSurg
379

285

315

Neurotechnology & Spine
218

176

142

Segment depreciation and amortization
$
945

$
811

$
794

Corporate and Other
99

155

65

Total depreciation and amortization
$
1,044

$
966

$
859

Orthopaedics
$
1,907

$
1,804

$
1,681

MedSurg
1,635

1,444

1,228

Neurotechnology & Spine
846

700

631

Segment operating income
$
4,388

$
3,948

$
3,540

Items not allocated to segments:
 
 
 
Corporate and Other
$
(480
)
$
(431
)
$
(402
)
Acquisition and integration-related charges
(275
)
(123
)
(64
)
Amortization of intangible assets
(464
)
(417
)
(371
)
Restructuring related and other charges
(226
)
(220
)
(194
)
Medical device regulations
(62
)
(12
)
—

Recall-related matters
(192
)
(23
)
(173
)
Regulatory and legal matters
24

(185
)
(39
)
Consolidated operating income
$
2,713

$
2,537

$
2,297


Segment Assets and Capital Spending
Assets:
2019
2018
2017
Orthopaedics
$
9,085

$
8,873

$
7,486

MedSurg
12,066

10,417

9,759

Neurotechnology & Spine
7,646

7,260

4,105

Total segment assets
$
28,797

$
26,550

$
21,350

Corporate and Other
1,370

679

847

Total assets
$
30,167

$
27,229

$
22,197

Capital spending:
 
 
 
Orthopaedics
$
125

$
134

$
138

MedSurg
265

217

194

Neurotechnology & Spine
29

31

50

Total segment capital spending
$
419

$
382

$
382

Corporate and Other
230

190

216

Total capital spending
$
649

$
572

$
598


We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related charges, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally cash and cash equivalents, marketable securities and property, plant and equipment.
The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based off the geographic area of the Stryker location where the sales to the customer originated.
Geographic Information
 
Net Sales
 
Net Property, Plant and Equipment
 
2019
2018
2017
 
2019
2018
United States
$
10,957

$
9,848

$
9,059

 
$
1,561

$
1,348

Europe, Middle East, Africa
1,888

1,793

1,567

 
838

669

Asia Pacific
1,617

1,532

1,413

 
95

96

Other countries
422

428

405

 
73

178

Total
$
14,884

$
13,601

$
12,444

 
$
2,567

$
2,291